EYEN: Eyenovia, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.52
Enterprise Value ($M) 7.90
Book Value ($M) 3.72
Book Value / Share 1.78
Price / Book 0.95
NCAV ($M) -7.39
NCAV / Share -3.53
Price / NCAV -0.48

Profitability (mra)
Return on Invested Capital (ROIC) -2.26
Return on Assets (ROA) -1.31
Return on Equity (ROE) -4.20

Liquidity (mrq)
Quick Ratio 0.55
Current Ratio 0.74

Balance Sheet (mrq) ($M)
Current Assets 11.69
Assets 22.80
Liabilities 19.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
12-04 13D/A Grant Stuart M. 3.96 -27.70
11-14 13G/A Armistice Capital, Llc 9.95 96.44
07-18 13D/A Ianchulev Tsontcho 3.20 -7.93

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A Amendment No. 1
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-24 24,307 113,691 21.38
2025-02-21 16,568 76,350 21.70
2025-02-20 80,180 268,092 29.91
2025-02-19 39,860 102,295 38.97

(click for more detail)

Similar Companies
ERNA – Eterna Therapeutics Inc. ESLA – Estrella Immunopharma, Inc.
EVOK – Evoke Pharma, Inc. FBIO – Fortress Biotech, Inc.
FBRX – Forte Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.